SEND V4.0 – What to Expect and When to Expect It
2025 年 4 月 24 日 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…
Danielle Pillsbury2025 年 4 月 24 日
Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis
2025 年 2 月 24 日 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…
Danielle Pillsbury2025 年 2 月 24 日
The Benefits of Real-Time Nonclinical Safety Data Analysis
Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…
Danielle Pillsbury2025 年 1 月 27 日
CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know
2024 年 12 月 3 日 The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for…
Danielle Pillsbury2024 年 12 月 3 日
Transforming Non-clinical Drug Development with SEND Explorer
Since 1999, Genmab has been developing therapeutic antibodies and antibody-drug conjugates (ADCs) for treating cancer.…
Danielle Pillsbury2024 年 7 月 8 日
What’s New for SEND 2023
This webinar will focus on several changes to the CDISC SEND standard that became active…
Danielle Pillsbury2023 年 6 月 12 日
Data Visualization with SEND Data to See What Happened at the Preclinical Phase
SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…
Danielle Pillsbury2023 年 2 月 9 日
